← Leaderboards
Ben Julian Palanca
Washington University
$4,322,083
Attributed
$6,061,524
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,061,524 · 5
By mechanism
U01$2,811,399 · 1
R01$2,447,600 · 2
R21$802,525 · 2
Top collaborators
- Eric J Lenze4 shared
- Robert D Sanders3 shared
- Shinung Ching1 shared
Most similar at Washington University
Same institution · by research overlap
- David A Harris$28,262,949
- Steven J Mennerick$16,806,295
- Eric J Lenze$35,080,787
- John P. Rice$13,697,998
- Paul J Shaw$11,314,044
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBiological MarkersImpaired CognitionSeveritiesPhysiologicalFutureDesignEvaluationPostoperative DeliriumCognitiveElderlyS Disease Related DementiaInsightDensityPerioperativeSlow-Wave SleepNeurologicDeliriumOperative Surgical ProceduresComplicationIncidencePostoperative PeriodConfusion Assessment MethodCognitive Function
Grant awards (15)
Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Trial$699,647
U01 · FY2025 · MH · contact PI
SCH: Mechanism-based dose titration for modifying brain electrophysiology during antidepressant therapy$284,333
R01 · FY2025 · MH
Mitigating Delirium with Fluvoxamine Treatment for Non-Cardiac Surgery (MD FluNCS): Feasibility Trials & Mechanistic Insights$107,129
R21 · FY2025 · AG · contact PI
Mitigating Delirium with Fluvoxamine Treatment for Non-Cardiac Surgery (MD FluNCS): Feasibility Trials & Mechanistic Insights$60,596
R21 · FY2025 · AG · contact PI
Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Trial$701,625
U01 · FY2024 · MH · contact PI
Mitigating Delirium with Fluvoxamine Treatment for Non-Cardiac Surgery (MD FluNCS): Feasibility Trials & Mechanistic Insights$215,425
R21 · FY2024 · AG · contact PI
Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Trial$706,890
U01 · FY2023 · MH · contact PI
Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Trial$703,237
U01 · FY2022 · MH · contact PI
POSTOPERATIVE DELIRIUM AND ELECTROENCEPHALOGRAPHIC MEASURES OF SLEEP AND WAKEFULNESS$306,397
R01 · FY2022 · AG · contact PI
POSTOPERATIVE DELIRIUM AND ELECTROENCEPHALOGRAPHIC MEASURES OF SLEEP AND WAKEFULNESS$466,444
R01 · FY2021 · AG · contact PI
POSTOPERATIVE DELIRIUM AND ELECTROENCEPHALOGRAPHIC MEASURES OF SLEEP AND WAKEFULNESS$461,353
R01 · FY2020 · AG · contact PI
POSTOPERATIVE DELIRIUM AND ELECTROENCEPHALOGRAPHIC MEASURES OF SLEEP AND WAKEFULNESS$468,552
R01 · FY2019 · AG · contact PI
POSTOPERATIVE DELIRIUM AND ELECTROENCEPHALOGRAPHIC MEASURES OF SLEEP AND WAKEFULNESS$460,521
R01 · FY2018 · AG · contact PI
THE DEFAULT MODE NETWORK DURING THE PATHOGENESIS OF POSTOPERATIVE DELIRIUM$190,625
R21 · FY2017 · AG · contact PI
THE DEFAULT MODE NETWORK DURING THE PATHOGENESIS OF POSTOPERATIVE DELIRIUM$228,750
R21 · FY2016 · AG · contact PI